Last updated on March 2020

Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients

Brief description of study

To characterize the pharmacokinetics (PK) of naloxegol after single oral dose and through population PK in paediatric patients with opioid induced constipation (OIC) or at risk of OIC.

Clinical Study Identifier: NCT02099591

Find a site near you

Start Over

Research Site

Phoenix, AZ United States
  Connect »


Copenhagen, Denmark
  Connect »

Royal Marsden Hospital

London, United Kingdom
  Connect »